摘要
目的 :探讨用阿托伐他汀和低分子肝素钙治疗不稳定型心绞痛的临床效果。方法 :对2012年11月至2015年11月期间我院收治的96例不稳定型心绞痛患者的临床资料进行回顾性研究。我们将这96例患者随机分为试验组和常规组,每组各有48例患者。为常规组患者使用常规疗法进行治疗,在此基础上,为试验组患者加用阿托伐他汀和低分子肝素钙进行治疗。治疗结束后,比较两组患者治疗的效果和不良反应的发生率。结果 :试验组患者进行治疗的总有效率明显高于常规组患者,差异有统计学意义(P<0.05)。两组患者不良发应的发生率相比差异无统计学意义(P>0.05)。结论 :用阿托伐他汀和低分子肝素钙治疗不稳定型心绞痛的临床效果确切。此疗法值得在临床上推广应用。
Objective：Review unstable angina pectoris atorvastatin therapy combined with low molecular weight heparin clinical efficacy and safety. Methods：We now choose the hospital where I treated 96 cases of unstable angina patients to participate in this survey, by way of a randomized controlled study will be divided into two groups, a control group of 48 patients receivedβ-blockers, nitrates Conventional drugs, angiotensin-converting enzyme inhibitors, anti-platelet aggregation, etc., in the experimental group 48 cases on the basis of the chase atorvastatin and low molecular weight heparin therapy, treatment for 2w, later assessment were compared angina pectoris, Differences electrocardiogram efficacy, while Comments drug safety. Results：The experimental group angina total efficiency and total efficiency of the ECG were 93.8%, 91.7%, compared to 72.9%in the control group, 68.9%was significantly higher （P〈0.05）;the two groups showed no obvious serious adverse reaction. Conclusion：unstable angina pectoris atorvastatin combined with low molecular weight heparin therapy for lowering blood lipids and control angina have a significant effect, and no significant adverse reactions, safe and reliable, with high clinical value.
